drugset

drugset / Trial / NCT01179620

Certoparin in Renal Patients Undergoing Hemodialysis

NCT01179620 ↗

Phase 3 Completed 109 enrolled Novartis

NaSingle-groupOpen-labelPrevention

Summary

This study will assess the efficacy, safety and pharmacokinetics of certoparin when used to prevent clotting during hemodialysis.

Timeline

Start: 2010-11
Primary completion: 2011-03
Completion: 2011-03

Publications

Dorsch O, Krieter DH, Lemke HD, Fischer S, Melzer N, Sieder C, Bramlage P, Harenberg J. A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study. BMC Nephrol. 2012 Jun 28;13:50. doi: 10.1186/1471-2369-13-50.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Certoparin	Other / unclassified	3000 iu	Intravenous

Indications

No indication recorded.